Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study

Helen Kovari, Caroline A Sabin, Bruno Ledergerber, Lene Ryom Nielsen, Signe W Worm, Colette Smith, Andrew Phillips, Peter Reiss, Eric Fontas, Kathy Petoumenos, Stéphane De Wit, Philippe Morlat, Jens D Lundgren, Rainer Weber

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    40 Citationer (Scopus)

    Abstract

    Liver diseases are the leading causes of death in human immunodeficiency virus (HIV)-positive persons since the widespread use of combination antiretroviral treatment (cART). Most of these deaths are due to hepatitis C (HCV) or B (HBV) virus coinfections. Little is known about other causes. Prolonged exposure to some antiretroviral drugs might increase hepatic mortality.
    OriginalsprogEngelsk
    TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
    Vol/bind56
    Udgave nummer6
    Sider (fra-til)870-9
    Antal sider10
    DOI
    StatusUdgivet - mar. 2013

    Citationsformater